New asthma inhaler passes first safety check in small study
NCT ID NCT06385964
First seen Mar 26, 2026 · Last updated May 09, 2026 · Updated 5 times
Summary
This early-stage study tested a new inhaler medicine called SHR-4597 in 62 people—some healthy and some with asthma. The main goal was to see if it is safe and tolerable. Researchers gave single doses to healthy volunteers and multiple doses over 16 days to asthma patients, monitoring for side effects. This is a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 200433, China
Conditions
Explore the condition pages connected to this study.